Assessing the risks in annuity pricing models
The number of companies targeting the development of new cell and gene therapies has risen dramatically in recent years. On a global scale, clinical research...
Walter Colasante is a vice president in the Life Sciences Practice at CRA. He has experience in both the pharmaceutical and consulting industries. Walter has experience across a range of different therapeutic areas, most notably oncology, CNS, and rare diseases.
Prior to his role at CRA, Walter was a senior principal at QuintilesIMS, now doing business as IQVIA, consulting primarily in global market access strategies and EU parallel trade. Previously, he was Vice President with ICON, plc (formerly PriceSpectives) and General Manager Europe for Kantar Health (formerly MattsonJack). In the pharmaceutical industry, he held several clinical research positions for Allergan Europe in the UK and Allergan, Italy. At Novartis, he was International Brand Director for its retinal products franchise. He is fluent in Italian and French.